Skip to content

Released Nov 10, 2020, after the close

10-Q filed Nov 10, 2020, 41 days after period end · 0001636422-20-000084

Q3 2020 · 10-Q
Revenue$47.19M+19.7% vs Q3 2019+9.1% vs Q2 2020
Net Income-$27.33MN/M vs Q3 2019N/M vs Q2 2020
EPS Diluted-$0.68N/M vs Q3 2019N/M vs Q2 2020
Operating Income-$23,458,000N/M
Operating Cash Flowderived-$4,487,000N/M
Free Cash Flowderived-$5,018,000N/M
Margins · derived
Operating margin-49.7%+2.9 pt vs Q3 2019
Net margin-57.9%−3.6 pt vs Q3 2019

What the release said

The release

Same quarter

MetricQ3 2020Q3 2019Q3 2018
Revenue$47.19M$39.42M$32.87M
Net Income-$27.33M-$21.42M-$16.88M
EPS Diluted-$0.68-$1.40-$3.71

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR